Tech Company M&A Transactions
Abrika Pharmaceuticals Acquisition
Abrika Pharmaceuticals was purchased by Actavis. The deal occurred on 4/24/2007. The parties did not disclose the acquisition terms for the deal.
Transaction Overview
Company Name
Acquired By
Announced On
4/24/2007
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
13800 NW 2nd St 190
Sunrise, FL 33325
USA
Sunrise, FL 33325
USA
Phone
Website
Email Address
Overview
We are a specialty generic pharmaceutical company engaged in the formulation and commercialization of both controlled release (CR) and immediate release (IR) products utilizing our proprietary drug delivery technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alan Cohen
Chief Executive Officer
James New
Vice President
Scott Lodin
Vice President
Dale Martin
VP - R & D
Tim Weng
Browse more venture capital transactions:
Prev: 4/24/2007: Ryla Teleservices venture capital transaction
Next: 4/25/2007: Apacheta venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs